⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for breast epithelial hyperplasia

Every month we try and update this database with for breast epithelial hyperplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Protocol for Women at Increased Risk of Developing Breast CancerNCT00291096
Breast Cancer
30 Years - 65 YearsUniversity of Kansas Medical Center
Protocol for Women at Increased Risk of Developing Breast CancerNCT00291096
Breast Cancer
30 Years - 65 YearsUniversity of Kansas Medical Center
An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast CancerNCT00291122
Breast Cancer
celecoxib 400 m...
18 Years - University of Kansas Medical Center
An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast CancerNCT00291122
Breast Cancer
celecoxib 400 m...
18 Years - University of Kansas Medical Center
An Examination of Predictors of Indicators of Response to Letrozole 2.5 mgNCT00291109
Breast Cancer
letrozole 2.5 m...
18 Years - University of Kansas Medical Center
Protocol for Women at Increased Risk of Developing Breast CancerNCT00291694
Breast Cancer
celecoxib
placebo
18 Years - University of Kansas Medical Center
Protocol for Women at Increased Risk of Developing Breast CancerNCT00291135
Breast Cancer
letrozole
18 Years - University of Kansas Medical Center
Protocol for Postmenopausal Women at Increased Risk of Developing Breast CancerNCT00291083
Breast Cancer
18 Years - University of Kansas Medical Center
Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin DNCT01166763
Breast Cancer
vitamin D3
- 55 YearsUniversity of Kansas Medical Center
Protocol for Women at Increased Risk of Developing Breast CancerNCT00291135
Breast Cancer
letrozole
18 Years - University of Kansas Medical Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: